Assignee profile:

BRAHMS AKTIENGESELLSCHAFT

City:

Henningsdorf

Country:

Germany

Published Applications:

13

Last publication date:

2011-02-17

Patent Grants:

9

Last grant date:

2016-02-16

Top Inventors for applications by BRAHMS AKTIENGESELLSCHAFT

These are the the leading inventors for applications assigned to BRAHMS AKTIENGESELLSCHAFT:

Recent patent applications by BRAHMS AKTIENGESELLSCHAFT

BRAHMS AKTIENGESELLSCHAFT based in Henningsdorf, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2011-02-17 βœ… Patent 9,261,516 granted on 2016-02-16
US20110039283A1
Physics

Diagnosis and risk stratification using NT-proET-1

#2 | 2010-06-10 βœ… Patent 8,252,544 granted on 2012-08-28
US20100143953A1
Physics

Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patients

#3 | 2010-04-15
US20100093012A1
Physics

DIAGNOSIS AND RISK STRATIFICATION OF CARDIAC INSUFFICIENCY USING NEUROPHYSIN

#4 | 2010-02-25 βœ… Patent 8,465,941 granted on 2013-06-18
US20100047835A1
Physics

Procalcitonin-based diagnosis of infections or inflammatory diseases of the respiratory tract in a patient with heart failure

#5 | 2010-02-18 βœ… Patent 8,158,368 granted on 2012-04-17
US20100041064A1
Physics

Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin II

#6 | 2010-02-11 βœ… Patent 8,436,135 granted on 2013-05-07
US20100035289A1
Physics

Diagnosis and risk stratification by determining the marker CT-proADM

#7 | 2010-02-11
US20100035275A1
Physics

DIAGNOSIS AND RISK ASSESSMENT OF PANCREATIC DIABETES USING MR-PROADM

#8 | 2010-02-04 βœ… Patent 8,501,485 granted on 2013-08-06
US20100028921A1
Physics

Risk stratification for acute coronary syndrome by determining copeptin

#9 | 2008-09-18
US20080227751A1
Human necessities

METHOD AND AGENT FOR THE PREVENTION, INHIBITION AND TREATMENT OF SEPSIS

#10 | 2006-12-26 βœ… Patent 7,153,662 granted on 2006-12-26
US10476065
-

Inflammation-specific peptides and the uses thereof

#11 | 2006-02-16
US20060034837A1
Human necessities

Method and agents for the prevention, inhibition and therapy of cancers

#12 | 2005-04-07 βœ… Patent 7,358,058 granted on 2008-04-15
US20050074818A1
Human necessities

Method and agents for the diagnosis and therapy of chronic inflammatory intestinal disease

#13 | 2005-03-17 βœ… Patent 7,572,590 granted on 2009-08-11
US20050059104A1
Physics

Method for the diagnosis of sepsis with determination of CA 19-9

AssigneeID:

212285 ⎘